γ-Tocotrienol but Not γ-Tocopherol Blocks STAT3 Cell Signaling Pathway through Induction of Protein-tyrosine Phosphatase SHP-1 and Sensitizes Tumor Cells to Chemotherapeutic Agents
Open Access
- 1 October 2010
- journal article
- retraction
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (43), 33520-33529
- https://doi.org/10.1074/jbc.m110.158378
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseasesBiochemical Pharmacology, 2010
- A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cellsLife Sciences, 2009
- Tocotrienols: The Emerging Face of Natural Vitamin EVitamins & Hormones, 2007
- Tocotrienols in health and disease: The other half of the natural vitamin E familyMolecular Aspects of Medicine, 2007
- Proteasome inhibitor bortezomib for the treatment of multiple myelomaLeukemia, 2006
- STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cellsBiochemical Journal, 2005
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Involvement of Tyrosine Phosphatase PTP1D in the Inhibition of Interleukin-6-Induced Stat3 Signaling by α-ThrombinBiochemical and Biophysical Research Communications, 2001
- STATs in oncogenesisOncogene, 2000
- Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienolsNutrition and Cancer, 1999